Proactiveinvestors USA & Canada Antibe Therapeutics https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Antibe Therapeutics RSS feed en Sun, 18 Aug 2019 01:49:43 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - NA Proactive news snapshot: Phunware, Dyadic International, Bragg Gaming, Ipsidy ... ]]> https://www.proactiveinvestors.com/companies/news/900670/na-proactive-news-snapshot-phunware-dyadic-international-bragg-gaming-ipsidy--900670.html Tue, 13 Aug 2019 10:50:00 -0400 https://www.proactiveinvestors.com/companies/news/900670/na-proactive-news-snapshot-phunware-dyadic-international-bragg-gaming-ipsidy--900670.html <![CDATA[News - NA Proactive news snapshot: GSRX Industries, CytoDyn, Great Panther Mining UPDATE … ]]> https://www.proactiveinvestors.com/companies/news/224582/na-proactive-news-snapshot-gsrx-industries-cytodyn-great-panther-mining-update--224582.html Fri, 26 Jul 2019 10:25:00 -0400 https://www.proactiveinvestors.com/companies/news/224582/na-proactive-news-snapshot-gsrx-industries-cytodyn-great-panther-mining-update--224582.html <![CDATA[News - NA Proactive news snapshot: ICC International Cannabis Corp, NexTech AR Solutions, Globex Mining Enterprises, WeedMD UPDATED … ]]> https://www.proactiveinvestors.com/companies/news/224372/na-proactive-news-snapshot-icc-international-cannabis-corp-nextech-ar-solutions-globex-mining-enterprises-weedmd-updated--224372.html Tue, 23 Jul 2019 17:20:00 -0400 https://www.proactiveinvestors.com/companies/news/224372/na-proactive-news-snapshot-icc-international-cannabis-corp-nextech-ar-solutions-globex-mining-enterprises-weedmd-updated--224372.html <![CDATA[News - Antibe Therapeutics to sell units to raise money to further develop lead osteoarthritis drug ]]> https://www.proactiveinvestors.com/companies/news/224378/antibe-therapeutics-to-sell-units-to-raise-money-to-further-develop-lead-osteoarthritis-drug-224378.html Tue, 23 Jul 2019 17:00:00 -0400 https://www.proactiveinvestors.com/companies/news/224378/antibe-therapeutics-to-sell-units-to-raise-money-to-further-develop-lead-osteoarthritis-drug-224378.html <![CDATA[News - Antibe Therapeutics is looking to the future after successful past year ]]> https://www.proactiveinvestors.com/companies/news/313988/antibe-therapeutics-is-looking-to-the-future-after-successful-past-year-13988.html Thu, 04 Jul 2019 13:40:00 -0400 https://www.proactiveinvestors.com/companies/news/313988/antibe-therapeutics-is-looking-to-the-future-after-successful-past-year-13988.html <![CDATA[News - Antibe Therapeutics hosts successful annual and special general meeting ]]> https://www.proactiveinvestors.com/companies/news/223238/antibe-therapeutics-hosts-successful-annual-and-special-general-meeting-223238.html Tue, 02 Jul 2019 19:56:00 -0400 https://www.proactiveinvestors.com/companies/news/223238/antibe-therapeutics-hosts-successful-annual-and-special-general-meeting-223238.html <![CDATA[News - Antibe Therapeutics updates on Phase 2 progress of lead drug ATB-346 ]]> https://www.proactiveinvestors.com/companies/news/222800/antibe-therapeutics-updates-on-phase-2-progress-of-lead-drug-atb-346-222800.html Tue, 25 Jun 2019 12:48:00 -0400 https://www.proactiveinvestors.com/companies/news/222800/antibe-therapeutics-updates-on-phase-2-progress-of-lead-drug-atb-346-222800.html <![CDATA[News - Antibe Therapeutics targets opioids with post-op pain drug ]]> https://www.proactiveinvestors.com/companies/news/313615/antibe-therapeutics-targets-opioids-with-post-op-pain-drug-13615.html Wed, 05 Jun 2019 11:49:00 -0400 https://www.proactiveinvestors.com/companies/news/313615/antibe-therapeutics-targets-opioids-with-post-op-pain-drug-13615.html <![CDATA[News - Antibe Therapeutics targets US$9 billion market with second pipeline drug ATB-352 for severe pain ]]> https://www.proactiveinvestors.com/companies/news/221396/antibe-therapeutics-targets-us9-billion-market-with-second-pipeline-drug-atb-352-for-severe-pain-221396.html Mon, 03 Jun 2019 08:25:00 -0400 https://www.proactiveinvestors.com/companies/news/221396/antibe-therapeutics-targets-us9-billion-market-with-second-pipeline-drug-atb-352-for-severe-pain-221396.html <![CDATA[News - Antibe Therapeutics CEO Dan Legault on why the multibillion-dollar NSAID market needs disruption ]]> https://www.proactiveinvestors.com/companies/news/221077/antibe-therapeutics-ceo-dan-legault-on-why-the-multibillion-dollar-nsaid-market-needs-disruption-221077.html Tue, 28 May 2019 16:08:00 -0400 https://www.proactiveinvestors.com/companies/news/221077/antibe-therapeutics-ceo-dan-legault-on-why-the-multibillion-dollar-nsaid-market-needs-disruption-221077.html <![CDATA[News - Antibe Therapeutics is a potential game changer in pain management ]]> https://www.proactiveinvestors.com/companies/news/313052/antibe-therapeutics-is-a-potential-game-changer-in-pain-management-13052.html Wed, 17 Apr 2019 16:09:00 -0400 https://www.proactiveinvestors.com/companies/news/313052/antibe-therapeutics-is-a-potential-game-changer-in-pain-management-13052.html <![CDATA[News - Antibe Therapeutic's Phase 2B trial safety results for pain drug ATB-346 published in British Journal of Pharmacology ]]> https://www.proactiveinvestors.com/companies/news/218693/antibe-therapeutic-s-phase-2b-trial-safety-results-for-pain-drug-atb-346-published-in-british-journal-of-pharmacology-218693.html Tue, 16 Apr 2019 07:54:00 -0400 https://www.proactiveinvestors.com/companies/news/218693/antibe-therapeutic-s-phase-2b-trial-safety-results-for-pain-drug-atb-346-published-in-british-journal-of-pharmacology-218693.html <![CDATA[News - Antibe Therapeutics is poised to disrupt the global pain management industry ]]> https://www.proactiveinvestors.com/companies/news/218520/antibe-therapeutics-is-poised-to-disrupt-the-global-pain-management-industry-218520.html Fri, 12 Apr 2019 16:53:00 -0400 https://www.proactiveinvestors.com/companies/news/218520/antibe-therapeutics-is-poised-to-disrupt-the-global-pain-management-industry-218520.html <![CDATA[News - Canadian shares halt 8-session rout ]]> https://www.proactiveinvestors.com/companies/news/119251/canadian-shares-halt-8-session-rout-119251.html Mon, 16 Nov 2015 12:54:00 -0500 https://www.proactiveinvestors.com/companies/news/119251/canadian-shares-halt-8-session-rout-119251.html <![CDATA[News - Antibe grants Kinght commercial rights for drug candidates ]]> https://www.proactiveinvestors.com/companies/news/119234/antibe-grants-kinght-commercial-rights-for-drug-candidates-119234.html Mon, 16 Nov 2015 09:32:00 -0500 https://www.proactiveinvestors.com/companies/news/119234/antibe-grants-kinght-commercial-rights-for-drug-candidates-119234.html <![CDATA[News - Antibe Therapeutics plunges 80% on suspending lead drug’s phase I clinical trial ]]> https://www.proactiveinvestors.com/companies/news/105093/antibe-therapeutics-plunges-80-on-suspending-lead-drugs-phase-i-clinical-trial-59314.html Fri, 16 Jan 2015 10:22:00 -0500 https://www.proactiveinvestors.com/companies/news/105093/antibe-therapeutics-plunges-80-on-suspending-lead-drugs-phase-i-clinical-trial-59314.html <![CDATA[News - Antibe Therapeutics seeks to fill market void with “ground-breaking” class of painkiller drugs ]]> https://www.proactiveinvestors.com/companies/news/97824/antibe-therapeutics-seeks-to-fill-market-void-with-ground-breaking-class-of-painkiller-drugs-48794.html Antibe Therapeutics is seeking to fill a vast market void with a “ground-breaking” class of painkiller drugs.  While the journey bringing the drug to market may be long and arduous, the end result appears to be well worth the toil, says president and CEO, Dan Legault. 

]]>
Wed, 09 Oct 2013 10:37:00 -0400 https://www.proactiveinvestors.com/companies/news/97824/antibe-therapeutics-seeks-to-fill-market-void-with-ground-breaking-class-of-painkiller-drugs-48794.html
<![CDATA[News - Antibe Therapeutics completes second tranche of IPO ]]> https://www.proactiveinvestors.com/companies/news/96877/antibe-therapeutics-completes-second-tranche-of-ipo-47121.html Wed, 14 Aug 2013 15:08:00 -0400 https://www.proactiveinvestors.com/companies/news/96877/antibe-therapeutics-completes-second-tranche-of-ipo-47121.html